Case Study: Producing high-value chemicals from renewable sources
Biotechnology company Visolis teamed up with the Agile BioFoundry to explore new feedstocks and microbes that are cheaper, more reliable, and perform well.
Agile BioFoundry Announces 2021 Directed Funding Opportunity
The Agile BioFoundry is overseeing a directed funding opportunity for industry and academic partners to utilize our capabilities.
Agile BioFoundry to participate in Global Biofoundries Alliance Webinar Series
Agile BioFoundry data scientist Tijana Radivojevic will participate in the first GBA webinar of 2021.
Machine Learning Takes on Synthetic Biology: Algorithms Can Bioengineer Cells for You
A new tool could drastically speed up the ability to design new biological systems.
Agile BioFoundry Selects New Projects to Accelerate Biomanufacturing
DOE announced the selection of eight projects totaling over $5 million to conduct research and development needed to accelerate the US biomanufacturing sector.
Agile BioFoundry Capabilities Available to Support COVID-19 Efforts
Our capabilities can be applied to the development of new therapeutics and diagnostics in the nation's response to the COVID-19 pandemic.
Agile BioFoundry Directed Funding Opportunity for 2020
We're seeking proposals that leverage the ABF's world-class capabilities to address challenges in biomanufacturing identified by industry and academia.